Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie Perry

Showing results (261-270 of 422) with videos related to

Pageof 43
Sort By:
Acta Neuropathologica|October 25, 2017
Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expressionGiselle Y Lopez, Nancy Ann Oberheim Bush, Joanna J Phillips, et al.
Brain Pathology (Zurich, Switzerland)|February 19, 2026
Alpha-B-crystallin immunohistochemistry: A sensitive but non-specific marker for epileptogenic lesionsEkin Güney, Ilay Caliskan, Tara Saunders, et al.
Alzheimer Disease and Associated Disorders|May 22, 2014
Variably Protease-sensitive Prionopathy in an Apparent Cognitively Normal 93-Year-OldNupur Ghoshal, Arie Perry, Daniel McKeel, et al.
Journal of Neuro-Oncology|February 27, 2018
Salvage therapy outcomes for atypical meningiomaWilliam C Chen, Jared Hara, Stephen T Magill, et al.
Acta Neuropathologica|September 28, 2018
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
Journal of Neuropathology and Experimental Neurology|May 17, 2005
INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinomaAlexander R Judkins, Peter C Burger, Ronald L Hamilton, et al.
Journal of Neuropathology and Experimental Neurology|September 13, 2024
Epithelioid angiosarcoma arising from pleomorphic xanthoastrocytoma, CNS WHO grade 3Austin J Helmink, Kanish Mirchia, Frank M Mezzacappa, et al.
Brain Pathology (Zurich, Switzerland)|May 10, 2012
Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q lossYoung-Ho Kim, Naosuke Nonoguchi, Werner Paulus, et al.
Acta Neuropathologica Communications|June 11, 2020
DNA methylation profiling demonstrates superior diagnostic classification to RNA-sequencing in a case of metastatic meningiomaHarish N Vasudevan, Maria R H Castro, Julieann C Lee, et al.
Journal of Neuropathology and Experimental Neurology|April 9, 2015
CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomasGerald F Reis, Melike Pekmezci, Helen M Hansen, et al.
Pageof 43

Showing results (261-270 of 422) with videos related to

Sort By:
Pageof 43
Acta Neuropathologica|October 25, 2017
Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expressionGiselle Y Lopez, Nancy Ann Oberheim Bush, Joanna J Phillips, et al.
Brain Pathology (Zurich, Switzerland)|February 19, 2026
Alpha-B-crystallin immunohistochemistry: A sensitive but non-specific marker for epileptogenic lesionsEkin Güney, Ilay Caliskan, Tara Saunders, et al.
Alzheimer Disease and Associated Disorders|May 22, 2014
Variably Protease-sensitive Prionopathy in an Apparent Cognitively Normal 93-Year-OldNupur Ghoshal, Arie Perry, Daniel McKeel, et al.
Journal of Neuro-Oncology|February 27, 2018
Salvage therapy outcomes for atypical meningiomaWilliam C Chen, Jared Hara, Stephen T Magill, et al.
Acta Neuropathologica|September 28, 2018
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
Journal of Neuropathology and Experimental Neurology|May 17, 2005
INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinomaAlexander R Judkins, Peter C Burger, Ronald L Hamilton, et al.
Journal of Neuropathology and Experimental Neurology|September 13, 2024
Epithelioid angiosarcoma arising from pleomorphic xanthoastrocytoma, CNS WHO grade 3Austin J Helmink, Kanish Mirchia, Frank M Mezzacappa, et al.
Brain Pathology (Zurich, Switzerland)|May 10, 2012
Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q lossYoung-Ho Kim, Naosuke Nonoguchi, Werner Paulus, et al.
Acta Neuropathologica Communications|June 11, 2020
DNA methylation profiling demonstrates superior diagnostic classification to RNA-sequencing in a case of metastatic meningiomaHarish N Vasudevan, Maria R H Castro, Julieann C Lee, et al.
Journal of Neuropathology and Experimental Neurology|April 9, 2015
CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomasGerald F Reis, Melike Pekmezci, Helen M Hansen, et al.
Pageof 43